SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-096449
Filing Date
2017-03-27
Accepted
2017-03-27 07:05:08
Documents
12
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d351374d20f.htm 20-F 1389737
2 EX-4.19 d351374dex419.htm EX-4.19 186655
3 EX-12.1 d351374dex121.htm EX-12.1 8549
4 EX-12.2 d351374dex122.htm EX-12.2 8535
5 EX-13.1 d351374dex131.htm EX-13.1 4889
6 EX-15.1 d351374dex151.htm EX-15.1 2992
7 GRAPHIC g351374g12k00.jpg GRAPHIC 51779
8 GRAPHIC g351374g13j65.jpg GRAPHIC 140740
9 GRAPHIC g351374g17j36.jpg GRAPHIC 158575
10 GRAPHIC g351374g62f83.jpg GRAPHIC 187308
11 GRAPHIC g351374g77m34.jpg GRAPHIC 26809
12 GRAPHIC g351374g91j07.jpg GRAPHIC 67817
  Complete submission text file 0001193125-17-096449.txt   2474583
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 17714158
SIC: 2834 Pharmaceutical Preparations